Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Celebrating 100 Episodes: Top MSL Insights, Career Tips, and Community Gratitude
Summary
In the milestone 100th episode of MSL Talk, Tom Caravela celebrates the journey of the podcast and extends gratitude to the supportive community. Reflecting on the podcast's evolution, Tom quizzes listeners on the most downloaded episode and revisits highlights and essential MSL attributes from the early days. He delves into topics like emotional intelligence, career transitions, and field medical excellence. The episode covers crucial aspects of career progression, market saturation, and effective job search strategies. Tom emphasizes the significance of diversity, networking, and personal growth, concluding with a heartfelt expression of gratitude and a recap of key insights.
Please join me for a very special MSL Talk Podcast milestone.
This episode marks our 100th since we started back on March 27th, 2020.
In this episode, I will offer some fun facts, statistics, and behind-the-scenes information, as well as provide a recap per category.
Special thanks to ALL of my awesome guests over the past 2 years and of course, thank YOU to our listeners throughout the world.
MSL Podcast, Medical Science Liaison, Career Progression, Emotional Intelligence, Networking Strategies
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Laleh Amiri-Kordestani & Richard Pazdur
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
Article
Nidal Al-Huniti, Yan Feng, Jingyu (Jerry) Yu, Zheng Lu, Mario Nagase, Diansong Zhou, Jennifer Sheng
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities
Article
Guillaume Beinse, MD, Virgile Tellier, Valentin Charvet, MSc, Eric Deutsch, MD, PhD, Isabelle Borget, PharmD, PhD, Christophe Massard, MD, PhD., Antoine Hollebecque, MD, PhD, and Loic Verlingue, MD
Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2
Article
Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD